Pharmaceutical company in the
Canton of Fribourg

Corden Pharma Fribourg SA

Since 1951 · 101–500 empl.·4.1(15)

Corden Pharma Fribourg SA is part of CordenPharma’s CDMO network and specializes in drug product development and GMP manufacturing. Its capabilities for small-molecule drug products span clinical development through commercialization.

UCB-Pharma SA

Since 2004 · 51–100 empl.·4.2(17)

UCB-Pharma SA manufactures medicines for allergies, epilepsy and autoimmune diseases. Its production activities include pharmaceutical manufacturing, chemical synthesis and biotechnology.

Phytopharma S.A.

Since 1993 · 11–20 empl.·4.8(9)

Phytopharma S.A. manufactures health products and distributes them through pharmacies, drugstores and health shops. Its range includes food supplements and foods, medical devices, lozenges, candies, cosmetics and bath products.

UCB Farchim SA

Since 1996 · 11–20 empl.·4.2(17)

UCB Farchim SA manufactures medicines for allergies, epilepsy and autoimmune diseases. Its production uses pharmaceutical processes, chemical synthesis and biotechnological platforms.

Vifor Pharma Switzerland SA

Since 2021 · 11–20 empl.·4.2(15)

Vifor Pharma Switzerland SA is a pharmaceutical company offering therapies and products for iron deficiency and iron-deficiency anaemia, as well as kidney and cardiorenal conditions. Its activities include research and development, production and commercialisation.

Dehly S.A.

Since 1985 · 1–10 empl.

Dehly S.A. develops and manufactures acacia gum pastilles for food products and medicines. Its services include custom formulation and support from defining product specifications through to launch.

Medistri SA

Since 2006 · 11–20 empl.

Medistri SA provides contract sterilisation, validation, packaging testing and contract manufacturing for medical devices and pharmaceutical products. It also operates a testing laboratory offering analyses in areas including microbiology, chemistry and biocompatibility.

GBT Pharma GmbH

Since 2010 · 1–10 empl.

GBT Pharma GmbH works in OTC market access and international business and product development. Its product portfolio includes, among others, cannaQIX, Klear-vol and Estroplus.

Chiesi SA

Since 2015 · 1–10 empl.

The core activity of OM Pharma Schweiz is the development, manufacture and marketing of pharmaceuticals, particularly for the treatment of urinary tract infections, respiratory diseases and central nervous system disorders. The company offers specific products such as Trimbow and Uro-Vaxom and primarily targets healthcare professionals in Switzerland.

Boiron SA

Since 2022 · 1–10 empl.

OM Pharma Suisse SA

Since 2020 · 101–500 empl.·3.9(10)

OM Pharma Suisse SA develops and commercializes medicines based on bacterial lysates to prevent and manage recurrent respiratory and urinary tract infections and to treat certain vascular conditions. The company conducts research, manufactures bacterial lysate products and collaborates with international distribution partners.

Creso Pharma Switzerland GmbH

Since 2023 · 1–10 empl.